$1.42
-0.04-3.08%
At close: -
$1.35
-0.06-4.59%
After Hours: 4:12 PM EDT
Comments
Loading...
Kazia Therapeutics (NASDAQ:KZIA) Stock, Earnings Estimates, EPS, And Revenue
Kazia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 15
EPS
$-0.066
Quarterly Revenue
$15.56M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$2.31M
Analyze the earnings history of Kazia Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Kazia Therapeutics (KZIA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Kazia Therapeutics (KZIA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Kazia Therapeutics (NASDAQ:KZIA) reporting earnings?
Kazia Therapeutics (KZIA) is scheduled to report earnings on March 26, 2025. The last reported earnings were for reported on November 15, 2024 for FY.
What were the latest earnings per share (EPS) for Kazia Therapeutics (NASDAQ:KZIA)?
The Actual EPS was $-0.07, which missed the estimate of $0.00.
What were Kazia Therapeutics’s (NASDAQ:KZIA) revenues?
The Actual Revenue was $15.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.